Key facts
- It has raised $12.1M; the latest was Early Stage VC ($12.1M) in Nov 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, Qiming Venture Partners, Beijing Delian Yuntong Investment Management Company, Shenzhen Longgang Financial Holding, LAV (Lilly Asia Fund) — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Hechun Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hechun Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hechun Medical
Manufacturer of advanced medical monitoring technologies intended for chronic disease management purposes. The company incorporates Class III medical device research, wearable smart monitoring hardware, physiological data collection functions, multi-parameter sensing components, long-term health-tracking algorithms, and system-level data processing capabilities, enabling healthcare providers and chronic disease management markets to perform continuous monitoring, support clinical decision making, improve patient oversight, and maintain stable long-term disease management workflows.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Website
- hechunmedical.com/
- Ownership
- Privately Held (backing)
Hechun Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hechun Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hechun Medical in its N-PORT filings yet. We sweep new filings monthly.